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Abstract
Alzheimer’s disease (AD) belongs to the class of neurodegenerative disorder and is biochemically characterized by amyloid-β
(Aβ) plaques deposition, accumulation of neurofibrillary tangles (NFTs) accumulation and ultimately neuronal loss. Even though,
the progress made in developing efficient AD therapy, there is no effective drug capable to stop and/or slow down AD progression.
In the current article, we investigated the neuroprotective effect of Khaya grandifololia crude extract and fraction 2 against Aβ42-
induced cytotoxicity and hyperphosphorylation of tau protein in differentiated neuronal cells (IMR32). Reactive oxygen species
production, apoptosis and mitochondrial dynamics and function, synaptic protein, and tau phosphorylation were evaluated using
fluorescence microscopy and immunoblotting. Cell viability was assessed using the MTT assay. Findings revealed that exposure
of differentiated IMR32 cells to Aβ42alone induced the impairment of mitochondrial dynamics, decrease synaptic protein expres-
sion and increase hyperphosphorylation of tau protein (phospho tau181). In contrast, the presence of crude extract and KGf2
significantly inhibited the cleavage of Caspase-3 activation. In addition, the levels of synaptic proteins (Symptosomal associated
protein 25 and Synaptosin) and superoxide dismutase were restored upon treatment with crude extract and fraction 2. Hyper-
phosphorylation of tau protein (Thr181) and ERK (Thr202/Tyr205) activities were also significantly reduced after treatment with
crude extract and fraction 2. Our findings suggest that KG extract is a potential source for candidate drug against AD and may
contribute to the development of efficient therapeutic strategy against AD.
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Introduction
Alzheimer’s disease (AD) belongs to the class of neurodegen-
erative disorder that affects the central nervous system and is
biochemically characterized by amyloid-β (Aβ) plaques depo-
sition, accumulation of neurofibrillary tangles (NFTs), and neu-
ronal loss with a cognitive impairment as consequence [1]. It pri-
marily affects elderly people over 65 years of age and account
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for 50-60% dementia cases [2, 3]. Approximately 47.5 million
people worldwide are affected by AD and the number of af-
fected people is expected to rise during the next 20 years [4, 5].
The pathological manifestations of AD and include extracellu-
lar amyloid beta deposits and intracellular tau protein abnormal-
ity characterized by hyperphosphorylated tau which eventually
forms neurofibrillary tangles (NFTs) inside the cells. In addi-
tion, synaptic dysfunction has been observed in other regions of
the brain [6]. Overall, clinical manifestations include progressive
memory loss, deterioration of intellectual functions, decreased
speech function, disorientation, and gait irregularities.
The prevalence of disease in a specific in population is de-
pendent on factors like incidence and survival. Therefore, AD
prevalence rises exponentially with age, increasing markedly af-
ter 65 years of age. AD in people 65 years of age and older was
about 6% [7]. Overall, approximately 47 million people world-
wide were living with AD in 2015 [8]. Since AD has become a
major public health because of an increasingly aging population.
Epidemiologic studies indicate that the worldwide prevalence of
AD will double by the year 2030 and triple by 2050. Regional
studies indicate that 3.6 million people in Asia live with AD and
in Europe, America and Africa 2.3, 1.2 and 0.5 million people
are affected, respectively [9].
Current Medications used for AD treatment include acetyl-
cholinesterase inhibitors (donepezil, tacrine and galantamine)
for mild to moderate cases, and memantine, an NMDA (N-
methylD-aspatarte)-receptor antagonist for the treatment of
moderate to severe AD. These drugs seem to be able to produce
modest symptomatic improvement in some patients [10].
However, no available medication appears to be able to cure
or stop AD progression. Previous investigations using medic-
inal plants that include Punica granatum, Vitis vinifera, Olea
europaea, Cinnamomum verum [11] have reported some anti-
amyloidogenic effects in transgenic mice and also in an in vitro
AD model [12]. In other investigations, medicinal plants extract
have shown neuroprotective activities [13], therefore can be use
or be helpful in the development of new drugs for Alzheimer’s
disease. For this purpose, we decided to screen Cameroonian
medicinal plants used in traditional medicine practices for anti-
AD activity. More specifically, Khaya grandifoliola (KG) is a
plant used in west Cameroon traditional medicine to combat var-
ious diseases including neurological disorders.
In addition, numerous investigation have shown that KG
possess various activities including anti-malarial, anti-bacterial,
anti-ulcer, anti-anaemic, anti-inflammatory, anti-fungal, hypo-
glycemic, hypocholesterolemic activities [14, 15]. In addition,
antioxidant, cytotoxic and hepato-protective effects have also
been reported [16, 17]. The current study was undertaken to
investigate the anti-amylodogenic activity of KG. To perform
this task, we first generated AD model by exposing differen-
tiated neuronal cells (IMR32) to amyloid beta peptide aggre-
gates (Aβ1−42). We found that IRM32 cells were sensitive to
Aβ–induced toxicity and also tau hyperphosphorylation as ob-
served in AD patients. Mitochondrial dysfunction was also ob-
served when exposing IMR32 cells to Aβ1−42. In contrast, pre-
vention of key parameters of neuronal dysfunction in AD such
as tau hyperphosphorylation, apoptosis, and mitochondrial dys-
function was observed in the presence of KG extract and frac-
tion.
Moreover, restoration of the level of reactive oxygen (ROS)
production and synaptic proteins (SNAP25 and SYP) was also
observed when IMR32 cells were exposed to Aß presence of
KG crude extract and its purified fraction. The present results
indicate KG possesses a neuroprotective activity, therefore may
be potentially considered in the process of the development of
new drug against AD.
Material and Methods
Chemicals
Aβ1−42 (rpeptide, Georgia, USA), 2’,7’-Dichlorofluorescin
diacetate (DCFH-DA), Hoescht 33342, propidium iodide
(PI), anti-rabbit IgG- alkaline phosphatase conjugated sec-
ondary antibody were from Sigma Aldrich, St. Louis, MO,
USA. Dulbecco’s Modified Eagle Medium (DMEM), Fetal
Bovine Serum (FBS) and 3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide (MTT) were obtained from Hi-
media Laboratories, India. Primary antibodies Cleaved Caspase-
3 (1:500), pERK (1:500), SOD (1:1000), SNAP25 (1:1000),
SYP (1:1000) from Cell Signaling, Beverly, MA; pT181-tau
(1:1000) from Santa Cruz Biotechnology, Santa Cruz, CA; and
β-actin (1:1000) from Sigma Aldrich, St. Louis, MO, USA.
Methods
Preparation of K haya grandifololia (KG) crude extract and
fraction 2
The stem bark of KG was collected in July 2017 in Foumban
in the West Region of Cameroon. The botanical identification
of the plant was done at the Cameroon National Herbarium in
Yaounde, where voucher specimens are kept under the reference
number 23434 YA. The collected plant material was washed
with distilled water, air-dried and powdered. A portion (200g)
of the powder was extracted twice with 2L of ethanol/water
65/35 (v/v) at room temperature with regular agitations during
48 hours. The extracts were filtered through Whatman paper
No.1, pooled, evaporated using a rotary evaporator and dried in
an oven (HP-AD070) at 50◦C and then subjected to silica gel
60/120 (particle size 40–63 µm) (MERCK, VetecTM, Germany)
column chromatography by eluting with a gradient of polarity
in the hexane/acetyl acetate (60/40 v/v); resulting in the collec-
tion of eight fractions. These eight fractions were analyzed using
thin layer chromatography (TLC) and combined into 2 fractions
labeled KGf1 and KGf2 based on the similarity of their TLC
profiles.
For the biological assays, the crude extract and fraction KGf2
were reconstituted in DMSO at a concentration of 50 mg/mL.
Preparation of oligomeric Aβ stock solution
The 42–amino acid version of Aβ peptide (Aβ42, rpeptide,
Georgia, USA) was dissolved in sterile 1% ammonium hydrox-
ide, sonicated for 30 s, and incubated at 37◦C for 5 days and was
used at a final concentration of 1 µM as previously reported [18].
Cell culture and differentiation
Human Neuroblastoma cell line IMR32 was purchased from Na-
tional Centre for Cell Science (NCCS, Pune, India). Cells were
maintained in Dulbecco Modified Essential Medium (DMEM)
supplemented with 10 % heat-inactivated fetal bovine serum,
a mixture of 1 % penicillin/streptomycin at 37 ◦C. Differenti-
ation was induced by exposing undifferentiated IMR32 cells to
retinoic acid (RA, 10 µM). Cell morphology was examined us-
ing an inverted microscope Primovert with digital camera Axiom
105 color (Zeiss, NY, USA) until cells were fully differentiated,
which was after 8 to 10 days of culture.
Cell treatment
To determine the effect of the crude extract and fraction 2 on dif-
ferentiated IMR32 cells physiology, cells were seeded at a den-
sity of 500,000 cells/well in 6-well plates and treated as follow:
(1) untreated IMR32 cells; (2) IMR32 cells incubated with Aβ42
(1 µM) alone; (3) IMR32 cells treated with the crude extract and
fraction 2 at 5 µg/mL and Aβ42 1 µM; (4) IMR32 cells treated
with the crude extract and fraction 2 alone at 5 µg/mL final con-
centration. Cells were incubated for 48 hr and the treatment was
terminated by removing the culture medium. Cells were washed
with PBS 1x before used for different assays.
Cytotoxicity assay
Test for cytotoxicty was done using 2-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly,
IMR32 cells were seeded in 96-well plates at a density of 3
000 cells/well and incubated with the plant extract and frac-
tions at different concentrations (0; 2; 5; 10, 20; 30; 40 and 50
µg/mL) for 48 hr. Then the culture medium was replaced by
fresh serum-free DMEM supplemented with 70 µL of MTT
(0.5 mg/mL) solution and the cells were further incubated at
37 ◦C for 4 hr. The medium was discarded and 200 µL of a
mixture of DMSO/Ethanol (1:1 V/V) was applied to the well to
dissolve the formazan derived from the mitochondrial cleavage
of the tetrazolium ring by live cells. The absorbance of the sol-
ubilized MTT formazan product was measured at 570 nm and
650 nm using a Multiskan microplate reader (Multiskan Sky,
ThermoFisher, MA, USA).
Morphological analysis of IMR32 cells
IMR32 cells treated with KG plant extracts or fraction 2 was
compared to untreated cells in order to determine the order to
determine the morphological by the plant extracts and fraction
2. IMR32 cells were seeded in 12-well plates, exposed to in-
creasing concentrations (0, 5, 15 and 25 µg/mL) of KG crude
extract and fraction 2 for 48 hr. The change in cell morphology
was determined by phase contrast microscopic analysis (Zeiss
Axiovert 100; 20 X magnification) (Zeiss, NY, USA).
Determination of cell apoptosis
Differentiated IMR32 cells were seeded and treated with
Aβ42and 5 µg/mL of the extract and fraction 2 for 48 h at 37◦C
and 5% CO2. After treatment, IMR32 cells were washed with
PBS and fixed in 4% paraformaldehyde for 30 min. After that,
cells were washed again with PBS and stained with propidium
Iodide (PI) (20 µg/mL) and Hoechst 33342 (5 µg/mL). Cells
were incubated in dark for 30 min at room temperature. The in-
cubated cells were washed again with PBS and analyzed under
by fluorescent microscopy using cell imager ZOETM (BioRad,
Portland, USA).
Determination of intracellular ROS generation
Differentiated IMR32 cells were treated with Aβ42with or with-
out KG crude extract and fraction 2 (5 µg/mL) for 48 hr. At the
end of the incubation period, treated and untreated cells were
incubated with 25 µM 2’,7’–dichlorofluorescin diacetate (DCF-
DA) at 37 ◦C in dark for 45 min followed by washing with PBS.
The intracellular levels of Reactive Oxygen Species (ROS) gen-
eration were monitored by fluorescence detection of DCF that is
proportional to the level of production of intracellular ROS. The
fluorescence was captured by a fluorescent cell imager ZOETM
(BioRad, Portland, USA) at an excitation and emission wave-
length of 488 nm and 560 nm, respectively.
Protein extraction and Western blot
Human neuroblastoma IMR32 cells were cultured in T25 flasks
to 80% confluency. Cells were seeded into 6-well plates at a
density of 5.0 × 105cells/well and incubated in the presence
of retinoic acid (RA) for 8-10 days. Differentiated cells were
further cultured with and without KG extract and/or fraction
2 (5 µg/mL) in the presence of Aβ42peptide for 48 hr. Cells
were then harvested and rinsed with ice-cold PBS and incubated
with 150 µL of lysis buffer (50mM Tris-HCl buffer pH 7.2; 2%
SDS) containing a cocktail of protease inhibitor (Thermo Sci-
entific Ltd, MA, USA) on ice and incubated for 30 min. Cell
homogenate was then obtained by using a cell scraped and son-
icated. The protein extracts were obtained by centrifugation at
14000 × g for 10 min at 4◦C. Supernatant (total cell protein)
was collected and protein concentration determined using Bicin-
choninic Acid (BCA) assay kit (Thermo Scientific, MA, USA).
Thirty (30) microgram of total protein extract was separated
on 12% SDS–PAGE and blotted onto nitrocellulose membrane
(Bio-Rad, Portland, USA). The membranes were incubated in
5% skimed milk for 2 hours under agitation at room temper-
ature. The membranes were further incubated with the appro-
priate primary antibodies [(cleaved Caspase-3, SOD, SNAP25,
SYP (Cell Signaling, Beverly, MA), β-actin (Sigma Aldrich,
MA, USA)] overnight at 4◦C. For pERK and pTau (Santa Cruz
Biotechnology, Santa Cruz, CA); membranes were blocked in
BSA before incubation with the appropriate primary antibody.
Membranes were washed with PBS three times for 10 min and
further incubated with the appropriate horseradish peroxidase-
conjugated secondary antibody for 2 hours at room temperature
under agitation. Proteins were visualized using chemilumines-
cence reagents (ThermoFisher Scientific, MA, USA). Relative
protein level was determined with normalization to β-actin sig-
nal by densitometry using ImageJ software.
Statistical analysis
Results of all analysis are presented as means ± standard devi-
ation (SD) (n = 3). Band intensities of fluorescence images and
western blots were quantified using ImageJ and expressed as rel-
ative values to the controls. Multiple comparisons were analyzed
by one-way ANOVA followed by Tukey’s test. Statistical anal-
yses were performed using GraphPad prism version 5.0. Differ-
ences were considered significant at p < 0.05.
Results
Prior to determine whether KG and fraction 2 prevent the β-
amyloid-induced toxicity in a human neuroblastoma (IMR32),
KG crude extract and fraction 2 were first tested for intrinsic
cytotoxicity. Undifferentiated IMR32 cells were incubated with
various concentrations of KG crude extract and fraction 2. The
cellular viability was estimated by the MTT assay. Results in-
dicate that KG crude extract and fractions 2 alone had no toxic
effect on differentiated IMR32 cells till 25 µg/mL (supplemental
figure 1). Our results indicates that lowest concentration of KG
crude extract and fraction 2, which is not cytotoxic to differenti-
ated IMR32 cells was 5 µg/mL (Supplemental figure 2) and used
for subsequent experiments.
Protective effect of KG extract and fraction 2 on Aβ42
-induced reactive oxygen species (ROS) production
and apoptosis.
Effects of KG crude extract and fraction 2 on Aβ42-induced ROS
production in cultured differentiated IMR32 cells are shown in
figure 1. Treatment of IMR32 cells for 48 hours using Aβ42 (1
µM) significantly increased the production of intracellular ROS.
Co-treatment of IMR32 cells with KG crude extract and fraction
2 with Aβ42 significant reduced the Aβ induced intracellular
ROS production.
In figure 2, treatment of IMR32 cells with KG crude extract
or fraction 2 alone significantly reduced the intracellular ROS
level, indicating that KG protect cells against Aβ-induced ROS
production.
.
The finding that the intracellular levels of reactive oxygen
species is controlled through the activities of SOD enzymes,
prompted us to investigate whether KG crude extract and frac-
tion 2 induces the affects ROS level through SOD enzymes activ-
ity. Therefore, IMR32 cells were treated with Aβ42 in the pres-
ence and absence of KG crude extract or fraction 2, and later to-
tal proteins were extracted from cells and were probed for SOD
by immunoblotting revealing. A significant decrease SOD pro-
tein expression in Aβ42-treated cells compared to control (figure
3A-D). However, the presence of KG crude extract and fraction
2 during Aβ42 treatment of IMR32 restores the level of SOD
protein expression (P<0.001).
It is shown that elevated ROS levels are also associated with
oxidative damage, increased deposition of Aβ42, the formation
of senile plaques and cell death. We assessed whether the KG
crude extract and fraction 2 protect cells from Aβ42 -induced
apoptosis.
The extract and fractions of KG Inhibit Cleaved
Caspase-3 in Aβ1−42 treated IMR32 cells
The effects of crude extract and fraction 2 of KG on cleaved
Caspase-3 expression were evaluated by western blot. As shown
in figure 3E-H, there was a significant up-regulation of caspase-
3 in Aβ-treated cells compared to control cells (P<0.001). How-
ever, treatment of these cells with crude extract and fraction 2 of
KG inhibit the cleavage of cleaved Caspase-3, confirming there-
fore KG possesses an anti-apoptotic activity.
KG extract and fraction 2 protect synaptic integrity
against Aβ42-induced synaptotoxicity
To assess synaptic integrity after Aβ1−42 treatment, we quan-
tified the expression of presynaptic vesicle membrane proteins
synaptosomal-associated protein 25 (SNAP-25) and synapto-
Figure 1 Effect of extract and fraction of KG on ROS level in Aβ42 induced IMR32 cells. ROS: reactive oxygen species; KG: Khaya
grandifololia. Aβ42: Amyloid beta 1-42. Scale bars, 100 µm.
Figure 2 Quantification of ROS level inAβ42 induced IMR32 cells. ROS: reactive oxygen species; KG: Khaya grandifololia. Aβ42: Amyloid
beta 1-42. ∗∗∗P<0.001 vs control; ###P<0.001 vs Aβ42 group
Figure 3 Effect of extract and fraction of KG on apoptosis induced by Aβ42 in IMR32 cells. (A, B) Effect of crude extract and fraction 2 of
KG on SOD activation, respectively. (C, D) Densitometry analysis of blots, respectively, for crude extract and fraction 2. (E, F) Effect of crude
extract and fraction 2 of KG on inhibition of cleavage of Caspase-3, respectively. (G, H) Densitometry analysis of blots, respectively, for crude
extract and fraction 2. ∗P<0.05; ∗∗∗P<0.001 vs control; ###P<0.001 vs Aβ42 group. Lane1: control; Lane2: Aβ42; Lane3: Aβ42 + KG or Aβ42 +
KGf2; Lane4: KG or KGf2. KG: Khaya grandifoliola, KGf2: fraction 2 of KG. Aβ42: Amyloid beta 1-42.
physin (SYP). Cells were treated without or with Aβ42 (1 µM),
or co-treated with Aβ42 (1 µM) and crude extract and frac-
tion 2 of KG (5 µg/mL) for 48 h. After treatment, total pro-
teins were extracted from cells and investigated for SNAP25
and SYP respectively. A western blot analysis showed a signif-
icant reduction of SNAP25 and SYP levels in Aβ1−42-treated
IMR32 cells compared to control, indicating a synaptic dysfunc-
tion (Fig. 4AB and Fig. 4EF). However, when IMR32 cells were
treated with Aβ42 in the presence of KG crude extract and frac-
tion 2, the expression level of SNAP-25 (Fig. 4AD) and SYP
(Fig. 4EH) were restored (P<0.001).
Extract and fraction 2 of KG inhibit
hyperphosphorylation of tau protein in Aβ1−42
-treated IMR32 cells
To determine whether KG crude extract and fraction 2 protect
tau protein phosphorylation, cells were treated without or with
Aβ42 (1 µM), or co-treated with Aβ42 (1 µM) and crude ex-
tract and fraction 2 of KG (5 µg/mL) for 48 h. After treatment,
total proteins were extracted from cells and the lysates were
probed for p-tau. As presented in figure 5, compared with the
control group, the level of tau phosphorylation at Thr181 residue
was significantly increased in the Aβ42 treated group (P<0.001).
Conversely, the levels of tau phosphorylation in the extract and
fraction KGf2 of KG groups were much lower than in the model
group (P<0.05 and P<0.001) respectively. The levels of tau phos-
Figure 4 Crude extract and fraction 2 of KG inhibited Aβ42-induced synaptotoxicity. (A, B) Effect of crude extract and fraction 2 of KG on
Snap25 activation, respectively. (C, D) Densitometry analysis of blots, respectively, for crude extract and fraction 2. (E, F) Effect of crude extract
and fraction 2 of KG on SYP activation, respectively. (G, H) Densitometry analysis of blots, respectively, for crude extract and fraction 2.
∗∗∗P<0.001, ∗∗P<0.01 vs control; ###P<0.001 vs Aβ42 group. Lane1: control; Lane2: Aβ42; Lane3: Aβ42 + KG or Aβ42 + KGf2; Lane4: KG or
KGf2. KG: Khaya grandifoliola, KGf2: fraction 2 of KG. Aβ42: Amyloid beta 1-42.
phorylation were most significantly decreased following treat-
ment with 5 µg/mL of extract and fraction KGf2.
Inhibition of ERK activity by crude extract and
fraction 2 of KG in IMR32 cells exposed to Aβ 42
The dysregulation of the ERK signaling pathway, which af-
fects tau hyperphosphorylation has been associated with the
Aβ1−42 model of AD. The increased level of phosphorylated
ERK at Thr202/Tyr204 is a reliable marker of the severity of
AD. To investigate whether KG crude extract and fraction 2 pre-
vents Aβ42 induced ERK hyperphosphorylation, Western blot-
ting using a pERK antibody specific for the detection of p-
ERK (Thr202/Tyr204) was performed. Differentiated IMR32
cells were treated with Aβ42 for 48 h and we found that Aβ42
significantly increased the levels of pERK. As shown in Figure 6,
phosphorylation levels of ERK were significantly elevated, indi-
cating that increased kinase activities might have contributed to
tau hyperphosphorylation following Aβ42 insult which was re-
duced upon KG crude extract and its purified fraction (P<0.001).
Discussion
The current investigation was undertaken to investigate whether
the Khaya grandifololia (KG) extracts prevent the differentiated
neuronal cell line (IMR32) from the β-amyloid induced toxic-
ity. Herein, KG crude extract or fraction 2 showed a preventive
activity against Aβ–induced cytotoxicity in IMR32 cells. More
Figure 5 Extract and fraction of KG inhibited tau hyperphosphorylation induced by Aβ42 in IMR32 cells. (A, B) Effect of crude extract and
fraction 2 of KG on pTau inhibition, respectively. (C, D) Densitometry analysis of blots, respectively, for crude extract and fraction 2. ∗∗∗P<0.001,
∗P<0.05 vs control; ###P<0.001, ##P<0.01 vs Aβ42 group. Lane1: control; Lane2: Aβ42; Lane3: Aβ42 + KG or Aβ42 + KGf2; Lane4: KG or
KGf2. KG: Khaya grandifoliola, KGf2: fraction 2 of KG. Aβ42: Amyloid beta 1-42.
Figure 6 pERK inhibition in response to Aβ42 in IMR32 cells by extract and fraction of KG. (A, B) Effect of crude extract and fraction 2 of
KG on pERK inhibition, respectively. (C, D) Densitometry analysis of blots, respectively, for crude extract and fraction 2. ∗∗∗P<0.001; ∗∗P<0.01 vs
control; ###P<0.001 vs Aβ42 group. Lane1: control; Lane2: Aβ42; Lane3: Aβ42 + KG or Aβ42 + KGf2; Lane4: KG or KGf2. KG: Khaya
grandifoliola, KGf2: fraction 2 of KG. Aβ42: Amyloid beta 1-42.
specifically, KG extracts prevented apoptosis by blocking the in-
tracellular ROS production and inhibition of caspase-3 upon ex-
posure of IRM32 to Aβ42. Moreover, we also observed a sig-
nificant protection of the synaptic integrity and inhibition of tau
hyperphosphorylation by KG extract upon exposure of IRM32
cell to Aβ42. Beside the prevention of Aβ42–induced cytotoxic-
ity by KG extracts observed in the current study, it has already
shown that KG extract possesses potent activity against acetyl-
choline esterase, one of the characteristics of Alzheimer disease
(AD) pathology and responsible for most AD symptoms includ-
ing memory decline and cognition [19]. The findings highlighted
in our study demonstrate that KG extracts may be considered as
potential therapeutic source in a strategy of new drug develop-
ment against AD.
It is shown that Aβ42 dyshomeostasis is one of the main
factors in AD pathogenesis [20], and this view point is ex-
panded towards a multi-target approach to achieve better thera-
peutic effects. Aβ is associated with oxidative stress in neuronal
cells and the exposure of differentiated neuronal IMR32 cells to
Aβ42 peptides resulted in elevated levels of intracellular reactive
oxygen species (ROS) and significantly decreased SOD activ-
ity. The consequence is the mitochondrial dysfunction due to a
change in the mitochondrial membrane permeability [21]. Thus,
the activity of antioxidant enzymes SOD is often considered a
biomarker of the resultant antioxidative response. In this study,
using the fluorescent activity as an indicator of the ROS produc-
tion, DCFH-DA staining demonstrates that the level of ROS in
Aβ42 induced IMR32 cells were remarkably higher than in the
control group. Treatment with KG crude extract and fraction 2
significantly reduced the level of ROS. Concerning antioxidant
status, the SOD activity from IMR32 cells treated with Aβ were
much lower than the control, but it was significantly reversed
following the treatment by crude extract and fraction 2 of KG.
The oxidative stress induced by Aβ creates a micro-
environment that promotes the onset of apoptosis [22]. In this
study, cell apoptosis was investigated using the PI/Hoescht
staining method. When IMR32 cells were exposed to Aβ42,
apoptotic features were obviously observed after PI and Hoescht
double staining, total apoptotic rate was increased, which could
be partially abrogated by the plant extract treatment. In order
to verify the effect of KG on this process, the caspase activity
was also measured. Caspases are serine-aspartyl proteases that
are involved in the initiation and execution of apoptosis [23].
Caspase-3 is essential for the implementation of the final step of
apoptosis and acts as an executioner [24]. Our results showed
that the level of cleaved Caspase-3 was higher in the Aβ42-
treated cells compared to the control group. Treatment with
extract and fractions of KG ameliorated the Aß42-induced up-
regulation of cleavage of Caspase-3 and significantly decreased
the level compared with Aβ42 treatment alone. The crude ex-
tract and fraction 2 of KG decreased expression of cleaved
caspase-3 and inhibits neuronal apoptosis in IMR32 cells. These
results agreed with the data from the above cytotoxicity assay,
suggesting that the ability of extract and fractions KG to at-
tenuate Aβ42-induced IMR32 cell death was mediated by its
anti-apoptotic activity [25].
Taking the mitochondrial apoptosis and oxidative stress re-
sults together, crude extract and fraction 2 of KG may inhibit
mitochondrial apoptosis-related oxidative stress.
Many studies showed that alterations in synaptic proteins ex-
pression are major contributors that precede neuronal loss in
AD [26]. Aβ accumulation cause synaptic toxicity. Synapto-
physin (SYP) and synaptosomal-associated protein 25 (SNAP-
25) levels are decreased in the brain of AD patients and Aβ-
induced toxicity in cells. The increase in the synaptic proteins
expression could be considered as an early option for treatment
of AD [27]. The results from our studies demonstrated that Aβ
induced an impaired synaptic structure and also significantly re-
duce the expression of synaptic proteins that include SNAP25
and SYP. However, crude extract and fraction 2 of KG could
obviously improve the expressions of synaptic related proteins
which are significantly increased after treatment.
These data suggest that the inhibition AD by KG may be me-
diated by the restoration of the expression of the synaptic pro-
teins.
More recent studies have found a better correlation between
tau and memory impairment in AD [28]. Tau hyperphosphory-
lation is a key event and important initial step in the degradation
of neurons occurring in the pathogenesis of AD and because the
microtubule structure of the neuron is destroyed after Tau ab-
normally phosphorylated [29]. In AD brains, hyperphosphoryla-
tion of tau protein occurred at several Ser or Thr phosphorylated
sites, including Thr181, Thr205, Ser202, Ser396, Ser404 [30].
The destabilization of the cytoskeletal dynamic, apoptosis and
ultimately memory dysfunction is caused by tau proteins hy-
perphosphorylation. It is obviously is an important task for re-
searcher to develop drugs that specifically target tau protein hy-
perphosphorylation in neuronal cells exposed to Aβ [30]. In the
present study, Aβ was used to construct the tau hyperphospho-
rylation model, treating IMR32 cells with 1 µM oligomeric pep-
tide Aβ42. After 48 hr, a cell model of tau hyperphosphorylation
was successfully established and the expression of Tau (pT181)
was significantly increased. The level of tau phosphorylation at
the site mentioned was reduced, following treatment of the cells
with crude extract and fraction 2 of KG at 5 µg/mL.
Therefore, compound of KG inhibited Aβ-induced hyper-
phosphorylation of tau. Moreover, extracellular signal regulated
kinase (ERK) is a kinase family involved in gene expression,
mitosis, metabolism, apoptosis, proliferation, differentiation and
movement. It can also affect tau phosphorylation in AD pathol-
ogy models [31]. Even though the mitogen-activated kinase
(MEK–ERK) pathway is important for neuronal survival, neu-
ronal death due to neurotoxic agents can be the consequence of
the aberrant activation of this pathway [18]. Our results showed
that crude extract and fraction 2 of KG inhibited the expression
of ERK showing that KG attenuates hyperphosphorylation of
Tau by inhibition of ERK.
AD’s drug discovery targeting the amyloid precursor proteins
(APP) and Aβ have so far not generated a successful disease
modifying candidate for this devastating pathology. Attention
to tau protein was almost completely left behind, even though
it forms aggregates in AD. Tangles are later manifestations of
tau pathology and soluble phosphorylated tau is the species re-
sponsible for neurodegenerative damage [28]. A large number
of herbal extracts, fractions, phytochemicals and herbal formula-
tions may possess anti-AD properties via their antioxidant, anti-
inflammatory, anti-apoptotic and anti-acetylcholinesterase activ-
ities, antiglycation, anti-β-amyloid aggregation, resulting in a
reduction in Aβ-induced toxicity [32].
In addition, the compounds with properties such as mitochon-
drial function protection, antiinflammation and anti-oxidant ac-
tivities may also provide the protective effect against neurode-
generation. However, potential beneficial effects of polyphenols,
flavonoids in AD may play a role in downstream targets such as
tau phosphorylation [33].
Conclusion
In summary, crude extract and fraction 2 of KG protected IMR32
cells from neuronal cell death induced by amyloid β by induc-
ing apoptosis, and it significantly attenuated the Aβ42-induced
hyperphosphorylation of tau at Thr181 through the inhibition of
phosphorylation of ERK. These results indicate that the extract
and fraction 2 of KG inhibited mitochondrial apoptosis, syn-
qptic toxicity and hyperphosphorylation of tau induced by Aβ.
Taken together, the results presented here increase our knowl-
edge about the neuroprotective effect of extract of KG, and sug-
gest this plant as a candidate for the development of phytother-
apeutic agents for Alzheimer’s disease and other tau pathology-
related neuronal degenerative diseases.
Abbreviations
AD: Alzheimer’s disease; Aβ: Amyloid beta; BCA: Bicin-
choninic acid assay; CNS: Central nervous system; DCF-DA:
2’,7’-dichlorofluorescein diacetate; DMEM: Dulbecco’s mod-
ified eagle medium; DMSO: Dimethylsulfoxide; ERK: Extra-
cellular signal regulated kinase; FBS: Fetal bovine serum; KG:
Khaya grandifololia; KGf2: fraction 2 de KG; NFTs: Neurofib-
rillary tangles; PI: Propidium iodide; pT181: PhosphoTau at
Thr 181; RA: Retinoid acid; ROS: Reactive oxygen species;
SNAP25: Symptosomal associated protein 25; SOD: Superoxide
dismutase; SYP: Synaptosin; TLC; Thin layer chromatography.
Acknowledgements
The first author of this article is grateful for the financial sup-
port rendered by the Department of Science and Technology
(DST) of the Government of India; and the Federation of Indian
Chambers of Commerce and Industry (FICCI) with the Research
Training Fellowship for Developing Countries Scientists (RTF-
DCS) (No.DCS/2018/000007).
Conflict of interest
The authors have declared no conflicts of interest.
Author contributions
FAE, SNF, FNN, and PFM defined the research subject and
the aims, designed the experiments. MS, PMK, and PFM pro-
vided facilities to perform the work. FAE, SCD, PMK performed
the experiments. FAE, SNF, FNN, MS, PMK and PFM analyzed
the data and wrote the paper.
All the authors read and approved the final version of this
manuscript.
Author details
1Department of Biochemistry, Faculty of Science, University
of Yaounde 1, Yaounde, Cameroon. 2Department of Studies
& Research in Biochemistry, Post Graduate Centre, Mangalore
University, Chikka Aluvara571232, Karnataka, Kodagu, India.
3Yenepoya Research Centre, Yenepoya (Deemed to be Univer-
sity), Mangalore575018, Karnataka, India. 4Faculty of Health
Science, Université des Montagnes, Bangangté, Cameroon.
References
[1] Li K, Wei Q, Liu FF, Hu F, Xie A, Zhu LQ, et al. Synaptic
Dysfunction in Alzheimer’s disease: Aβ, Tau, and Epige-
netic Alterations. MolNeurobiol. 2017;55(4):3021–3032.
[2] Francis PT, Palmer AM, Snape M, Wilcock GK. The
cholinergic hypothesis of Alzheimer’s disease: a review of
progress. Journal of Neurology, Neurosurgery & Psychi-
atry. 1999;66(2):137–147. Available from: https://dx.doi.
org/10.1136/jnnp.66.2.137.
[3] Ma WW, Tao Y, Wang YY, Peng IF. Effects of Garde-
nia jasminoides extracts on cognition and innate immune
response in an adult Drosophila model of Alzheimer’s dis-
ease. Chin J Nat Medicines. 2017;15(12):899–904.
[4] Zhifeng Z, Han J, Zhang J, Xiao Q, Hu J, Chen L. Phar-
macological activities, mechanisms of action, and safety of
salidroside in the central nervous system. Drug Des Dev
Ther. 2018;12:1479–1489.
[5] Poirier Y, Grimm A, Schmitt K, Eckert A. Link be-
tween the unfolded protein response and dysregulation
of mitochondrial bioenergetics in Alzheimer’s disease.
Cellular and Molecular Life Sciences. 2019;76(7):1419–
1431. Available from: https://dx.doi.org/10.1007/s00018-
019-03009-4.
[6] Xia W, Li DW, Xiang L, Chang JJ, Xia ZL, Han EJ. Neu-
roprotective effects of an aqueous extract of Futokadsura
stem in an Aβ-Induced Alzheimer’s disease-like rat model.
Chin J Physiol. 2015;58(2):104–113.
[7] Burns A, Iliffe S. Alzheimer’s disease. BMJ.
2009;338(feb05 1):b158–b158. Available from: https://dx.
doi.org/10.1136/bmj.b158.
[8] Mroczko B, Groblewska M, Litman-Zawadzka A, Korn-
huber J, Lewczuk P. Amyloid β oligomers (AβOs) in
Alzheimer’s disease. Journal of Neural Transmission.
2018;125(2):177–191. Available from: https://dx.doi.org/
10.1007/s00702-017-1820-x.
[9] Kuca K, Soukup O, Maresova P, Korabecny J, Nepovi-
mova E, Klimova B, et al. Current Approaches
Against Alzheimer’s Disease in Clinical Trials. Jour-
nal of the Brazilian Chemical Society. 2016;27(4):641–
649. Available from: https://dx.doi.org/10.5935/0103-
5053.20160048.
[10] Clark CM, Karlawish JHT. Alzheimer Disease: Cur-
rent Concepts and Emerging Diagnostic and Therapeutic
Strategies. Annals of Internal Medicine. 2003;138(5):400–
400. Available from: https://dx.doi.org/10.7326/0003-
4819-138-5-200303040-00010.
[11] Andrade S, Ramalho MJ, Loureiro JA, do Carmo Pereira
M. Natural Compounds for Alzheimer’s Disease Ther-
apy: A Systematic Review of Preclinical and Clinical
Studies. International Journal of Molecular Sciences.
2019;20(9):2313–2313. Available from: https://dx.doi.org/
10.3390/ijms20092313.
[12] Wang L, Jin GF, Yu HH, Lu XH, Zou ZH, Liang JQ. Pro-
tective effects of tenuifolin isolated from Polygala tenuifo-
lia Willd roots on neuronal apoptosis and learning and
memory deficits in mice with Alzheimer’s disease. Food
Funct. 2019;10:7453–7460.
[13] Ebrahimi A, Schluesener H. Natural polyphenols against
neurodegenerative disorders: Potentials and pitfalls. Age-
ing Research Reviews. 2012;11(2):329–345. Available
from: https://dx.doi.org/10.1016/j.arr.2012.01.006.
[14] Ijarotimi SO, Agbedahunsi JM, Onyeji CO, Co A.
Chemotherapeutic interaction between Khaya grandifoli-
ola (Welw) CDC stem bark extract and two anti-malarial
drugs in mice. Afr J Tradit Complement Altern Med.
2010;7(4):370–376.
[15] Hashem F, Aboutabl E, Souda SE, Moharam M, Mam-
moun A, Shabana M. Desmutagenic and antimuta-
genic potential of phenolics from Khaya grandifoliola
(C.DC.), Meliaceae. Egyptian Pharmaceutical Journal.
2013;12(2):148–148. Available from: https://dx.doi.org/
10.4103/1687-4315.124018.
[16] Njayou FN, Amougou AM, Tsayem RF, Manjia JN,
Rudraiah S, Bradley B, et al. Antioxidant fractions of
Khaya grandifoliola C.DC. and Entada africana Guill. et
Perr. induce nuclear translocation of Nrf2 in HC-04 cells.
Cell Stress and Chaperones. 2015;20(6):991–1000. Avail-
able from: https://dx.doi.org/10.1007/s12192-015-0628-6.
[17] Kouam AF, Yuan F, Njayou FN, He H, Tsayem RF,
Oladejo BO, et al. Induction of Mkp-1 and Nu-
clear Translocation of Nrf2 by Limonoids from Khaya
grandifoliola C.DC Protect L-02 Hepatocytes against
Acetaminophen-Induced Hepatotoxicity. Frontiers in
Pharmacology. 2017;8:653–653. Available from: https:
//dx.doi.org/10.3389/fphar.2017.00653.
[18] Modi PK, Komaravelli N, Singh N, Sharma P. In-
terplay between MEK-ERK signaling, cyclin D1, and
cyclin-dependent kinase 5 regulates cell cycle reentry and
apoptosis of neurons. Molecular Biology of the Cell.
2012;23(18):3722–3730. Available from: https://dx.doi.
org/10.1091/mbc.e12-02-0125.
[19] Jahn H. Memory loss in Alzheimer’s disease. Dialogues
Clin Neurosci. 2013;15(4):445–454.
[20] Forner S, Baglietto-Vargas D, Martini AC, Trujillo-Estrada
L, LaFerla FM. Synaptic Impairment in Alzheimer’s
Disease: A Dysregulated Symphony. Trends in Neuro-
sciences. 2017;40(6):347–357. Available from: https://dx.
doi.org/10.1016/j.tins.2017.04.002.
[21] Ali T, Yoon GH, Shah SA, Lee HY, Mo K. Osmotin at-
tenuates amyloid beta induced memory impairment, tau
phosphorylation and neurodegeneration in the mouse hip-
pocampus. Scientific Reports. 2015;5:11708–11708.
[22] Kim A, Nam YJ, Lee MS, Shin YK, Sohn DS, Lee CS.
Apigenin reduces proteasome inhibition-induced neuronal
apoptosis by suppressing the cell death process. Neu-
rochem Res. 2016;41(11):2969–2980.
[23] Zhuang J, Li Y, Chi Y. Role of p38 MAPK activa-
tion and mitochondrial cytochrome-c release in allicin-
induced apoptosis in SK-N-SH cells. Anti-Cancer Drugs.
2016;27:312–317.
[24] Wang Z, Lin D, Zhang L, Liu W, Tan H, Ma J. Pene-
hyclidine hydrochloride prevents anoxia/reoxygenation in-
jury and induces H9c2 cardiomyocyte apoptosis via a mi-
tochondrial pathway. Eur J Pharmacol. 2017;797:115–123.
[25] Chen Z, Tao S, Li X, Zeng X, Zhang M, Yao Q. Anagliptin
protects neuronal cells against endogenous amyloid β
(Aβ)-induced cytotoxicity and apoptosis. Artif Cell
Nanomed B. 2019;47(1):2213–2220.
[26] Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A,
Kandimalla R, et al. Protective effects of a natural prod-
uct, curcumin, against amyloid β induced mitochondrial
and synaptic toxicities in Alzheimer’s disease. Journal of
Investigative Medicine. 2016;64(8):1220–1234. Available
from: https://dx.doi.org/10.1136/jim-2016-000240.
[27] Daneshmand P, Saliminejad K, Shasaltaneh MD, Riazi
GH, Nazari R, Azimzadeh P, et al. Neuroprotective effects
of herbal extract (Rosa canina, Tanacetum vulgare and Ur-
tica dioica) on rat model of sporadic Alzheimer’s disease.
Avicenna J Med Biotech. 2016;8(3):120–125.
[28] Adwan L, Subaiea GM, Basha R, Zawia NH. Tolfe-
namic acid reduces tau and CDK5 levels: implications
for dementia and tauopathies. Journal of Neurochemistry.
2015;133(2):266–272. Available from: https://dx.doi.org/
10.1111/jnc.12960.
[29] Cao F, Wang Y, Peng B, Zhang X, Zhang D, Xu L. Effects
of celastrol on Tau hyperphosphorylation and expression
of HSF-1 and HSP70 in SH-SY5Y neuroblastoma cells in-
duced by amyloid-ß peptides. Biotechnol Appl Biochem.
2018;65(3):390–396.
[30] Yao Y, Wang Y, Chen Y, Yang J. Osthole decreases
tau protein phosphorylation via PI3K/AKT/GSK-3β sig-
naling pathway in Alzheimer’s disease. Life Sci.
2019;15(217):16–24.
[31] Jhang KA, Park JS, Kim HS, Chong YH. Resveratrol ame-
liorates tau hyperphosphorylation at Ser396 site and oxida-
tive damage in rat hippocampal slices exposed to vanadate:
Implication of ERK1/2 and GSK-3β signaling cascades. J
Agric Food Chem. 2017;64(44):9626–9634.
[32] Sereia AL, de Oliveira MT, Baranoski A, Marques LLM,
Ribeiro FM, Isolani RG, et al. In vitro evaluation of
the protective effects of plant extracts against amyloid-
beta peptide-induced toxicity in human neuroblastoma
SH-SY5Y cells. PLOS ONE. 2019;14(2):e0212089–
e0212089. Available from: https://dx.doi.org/10.1371/
journal.pone.0212089.
[33] Baptista FI, Henriques AG, Silva AMS, Wiltfang J,
da Cruz e Silva OAB. Flavonoids as Therapeutic Com-
pounds Targeting Key Proteins Involved in Alzheimer’s
Disease. ACS Chemical Neuroscience. 2014;5(2):83–92.
Available from: https://dx.doi.org/10.1021/cn400213r.
